The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis-Reference-Cited by-同舟云学术

The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis

Published:2019-07 Issue: Volume:59 Page:76-84
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Dang Qingxiu,Chen Lili,Xu Mengqi,You Xuefen,Zhou Hong,Zhang Yaping,Shi Wenyu^ORCID

Funder

National Youth Science Foundation

Top Six Talents in Jiangsu Province

National Natural Science Foundation of China

Science and Technology Project of Nantong City

Publisher

Elsevier BV

Subject

Cell Biology

Reference59 articles.

1. Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth;Hoareau-Aveilla,2015

2. Anaplastic large cell lymphoma, ALK-negative;Ferreri;Crit. Rev. Oncol. Hematol.,2013

3. From pathology to precision medicine in anaplastic large cell lymphoma expressing anaplastic lymphoma kinase (ALK+ ALCL);Werner;Cancers,2017

4. Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency;Ceccon;Oncogene,2016

5. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK(+) T-cell lymphoma;Shi;Mol. Oncol.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Notch‐Targeted Therapeutic in Colorectal Cancer by Notch1 Attenuation Via Tumor Microenvironment‐Responsive Cascade DNA Delivery;Advanced Healthcare Materials;2024-06-03

2. Corrigendum to “The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis.” [Cellular Signalling 59 (2019) 76–84.];Cellular Signalling;2024-01

3. Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target;Haematologica;2020-04-23

4. MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents;Cell Death & Disease;2019-10

5. Corrigendum to <‘The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis’> [Cellular Signalling 59 (2019) 76–84];Cellular Signalling;2019-07